Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

When History Has Its Eyes On You: Opill Vote Puts US FDA In Tough Spot

May 16 2023

• By Michael McCaughan

FDA and oral contraceptives — • Source: Nielsen Hobbs; the Pink Sheet | Shutterstock image

Related Content

First OTC Oral Contraceptive Has Advisory Panel’s Unanimous Support Despite FDA’s Data Concerns

May 11 2023

FDA May Ask HRA For Another OTC Birth Control Actual Use Study Due To ‘Improbable Dosing’

May 08 2023

Advisory Panel Members On Unanimous Vote Recommending US FDA Approve OTC Birth Control

May 16 2023

Related Companies

Perrigo Company PLC

Additional Topics

United States Advisory Committees Women's Health Drug Approval Standards OTC Drugs Regulation Drug Review Gynecology & Urology BioPharmaceutical

More from Regulation

More from Policy & Regulation

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window